These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 23044640

  • 41. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ, Goa KL.
    Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
    [Abstract] [Full Text] [Related]

  • 42. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.
    Wasdell MB, Jan JE, Bomben MM, Freeman RD, Rietveld WJ, Tai J, Hamilton D, Weiss MD.
    J Pineal Res; 2008 Jan; 44(1):57-64. PubMed ID: 18078449
    [Abstract] [Full Text] [Related]

  • 43. The use of prolonged-release melatonin in circadian medicine: a systematic review.
    Del Casale A, Arena JF, Giannetti F, Minervino A, Biggio G, Girardi P.
    Minerva Med; 2024 Apr; 115(2):125-142. PubMed ID: 38713204
    [Abstract] [Full Text] [Related]

  • 44. Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people.
    Arbon EL, Knurowska M, Dijk DJ.
    J Psychopharmacol; 2015 Jul; 29(7):764-76. PubMed ID: 25922426
    [Abstract] [Full Text] [Related]

  • 45. Melatonin in elderly patients with insomnia. A systematic review.
    Olde Rikkert MG, Rigaud AS.
    Z Gerontol Geriatr; 2001 Dec; 34(6):491-7. PubMed ID: 11828891
    [Abstract] [Full Text] [Related]

  • 46. Zaleplon: a review of its use in the treatment of insomnia.
    Dooley M, Plosker GL.
    Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
    [Abstract] [Full Text] [Related]

  • 47. Sublingual zolpidem (Edluar™; Sublinox™).
    Yang LP, Deeks ED.
    CNS Drugs; 2012 Nov; 26(11):1003-10. PubMed ID: 23034583
    [Abstract] [Full Text] [Related]

  • 48. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.
    Lancet; 2009 Feb 07; 373(9662):482-91. PubMed ID: 19054552
    [Abstract] [Full Text] [Related]

  • 49. Melatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study.
    Jain SV, Horn PS, Simakajornboon N, Beebe DW, Holland K, Byars AW, Glauser TA.
    Sleep Med; 2015 May 07; 16(5):637-44. PubMed ID: 25862116
    [Abstract] [Full Text] [Related]

  • 50. Eszopiclone for the treatment of primary insomnia: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.
    Liang L, Huang Y, Xu R, Wei Y, Xiao L, Wang G.
    Sleep Med; 2019 Oct 07; 62():6-13. PubMed ID: 31518944
    [Abstract] [Full Text] [Related]

  • 51. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.
    Zemlan FP, Mulchahey JJ, Scharf MB, Mayleben DW, Rosenberg R, Lankford A.
    J Clin Psychiatry; 2005 Mar 07; 66(3):384-90. PubMed ID: 15766306
    [Abstract] [Full Text] [Related]

  • 52. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC, Mungiu OC.
    Rev Med Chir Soc Med Nat Iasi; 2012 Mar 07; 116(3):862-6. PubMed ID: 23272543
    [Abstract] [Full Text] [Related]

  • 53. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial.
    Cortesi F, Giannotti F, Sebastiani T, Panunzi S, Valente D.
    J Sleep Res; 2012 Dec 07; 21(6):700-9. PubMed ID: 22616853
    [Abstract] [Full Text] [Related]

  • 54. Analgesic and sedative effects of melatonin in temporomandibular disorders: a double-blind, randomized, parallel-group, placebo-controlled study.
    Vidor LP, Torres IL, Custódio de Souza IC, Fregni F, Caumo W.
    J Pain Symptom Manage; 2013 Sep 07; 46(3):422-32. PubMed ID: 23195393
    [Abstract] [Full Text] [Related]

  • 55. Zolpidem extended-release.
    Moen MD, Plosker GL.
    CNS Drugs; 2006 Sep 07; 20(5):419-26; discussion 427-8. PubMed ID: 16696581
    [Abstract] [Full Text] [Related]

  • 56. Eszopiclone: a review of its use in the treatment of insomnia.
    Hair PI, McCormack PL, Curran MP.
    Drugs; 2008 Sep 07; 68(10):1415-34. PubMed ID: 18578559
    [Abstract] [Full Text] [Related]

  • 57. Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia.
    Uchiyama M, Hamamura M, Kuwano T, Nagata H, Hashimoto T, Ogawa A, Uchimura N.
    Sleep Med; 2011 Feb 07; 12(2):127-33. PubMed ID: 21277255
    [Abstract] [Full Text] [Related]

  • 58. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
    Black J, Pillar G, Hedner J, Polo O, Berkani O, Mangialaio S, Hmissi A, Zammit G, Hajak G.
    Sleep Med; 2017 Aug 07; 36():86-94. PubMed ID: 28735928
    [Abstract] [Full Text] [Related]

  • 59. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.
    Sleep Med; 2005 Nov 07; 6(6):487-95. PubMed ID: 16230048
    [Abstract] [Full Text] [Related]

  • 60. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
    Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T.
    Sleep; 2003 Nov 01; 26(7):793-9. PubMed ID: 14655910
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.